[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338430-105":59,"doc-detail-338430-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","germline-polymorphisms-of-the-nod2-pathway-may-predict-the-effectiveness-of-radioiodine-in-differentiated-thyroid-cancer-treatment","Germline polymorphisms of the NOD2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment","","Differentiated thyroid cancer (DTC) remains clinically challenging, particularly for patients with distant metastases and resistance to standard therapies. This study retrospectively evaluated whether germline single nucleotide polymorphisms (SNPs) within genes related to inflammatory pathways and neoplastic processes associate with DTC clinical and pathological features and with radioiodine (RAI) treatment efficacy. Associations were tested in 646 post-thyroidectomy patients, assessing genetic profiles for links to RAI response and tumor pathology.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/germline-polymorphisms-of-the-nod2-pathway-may-predict-the-effectiveness-of-radioiodine-in-differentiated-thyroid-cancer-treatment/338430/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/germline-polymorphisms-of-the-nod2-pathway-may-predict-the-effectiveness-of-radioiodine-in-differentiated-thyroid-cancer-treatment/338430.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the purpose of this study on DTC and radioiodine therapy?","Question",{"text":112,"@type":113},"The study aimed to determine how specific genes and their germline SNPs, especially those linked to inflammatory and other neoplastic processes, relate to DTC characteristics and to the effectiveness of radioiodine (RAI) treatment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the patient cohort structured and what genetic testing method was used?",{"text":117,"@type":113},"The retrospective cohort included 646 DTC patients diagnosed after thyroidectomy (study period 1998–2014, updated in 2023). SNP selection focused on functional significance, and mutational status was assessed by pyrosequencing.",{"name":119,"@type":110,"acceptedAnswer":120},"Which genetic variants were highlighted as markers for tumor subtype and RAI response?",{"text":121,"@type":113},"The NOD2 c.802 T>C variant (rs2066842) helped distinguish papillary thyroid cancer (PTC) from follicular thyroid cancer (FTC), and the NOD2 c.802 T allele was associated with a stronger RAI response, reflected by greater post-treatment stimulated thyroglobulin (sTg) decrease.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338430,1790143806,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Journal of Endocrinological Investigation (2024) 47:2969–2980  \n[https://doi.org/10.1007/s40618-024-02389-0](https://doi.org/10.1007/s40618-024-02389-0)  \nGermline polymorphisms ofthe NOD2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment  \nM. Borowczyk1 · M. Kaczmarek‑Ryś2 · S. Hryhorowicz2 · M. Sypniewski3 · D. Filipowicz1 · P. Dobosz3,4 · M. Oszywa1 ·  \nM. Ruchała1 · K. Ziemnicka1,3  \nReceived: 27 January 2024 / Accepted: 2 May 2024 / Published online: 16 May 2024 © The Author(s) 2024  \nAbstract  \nPurpose Differentiated thyroid cancer (DTC) presents a complex clinical challenge, especially in patients with distant metastases and resistance to standard treatments. This study aimed to investigate the influence of specific genes and their germline single nucleotide polymorphisms (SNPs) linked to both inflammatory processes and other neoplasms on the clinical and pathological characteristics of DTC, particularly their potential impact on radioiodine (RAI) treatment efficacy.  \nMethods This retrospective analysis involved a cohort of 646 patients diagnosed with DTC after thyroidectomy. Study covering 1998–2014, updated in 2023, included 567 women and 79 men (median age: 49; range: 7–83) . SNP selection targeted functional significance, while mutational status was assessed by pyrosequencing for comprehensive characterization. Patient genetic profiles were assessed for associations with disease characteristics, RAI response, and cancer pathology.  \nResults Significant correlations emerged between certain SNPs and DTC features. Notably, the NOD2 c.802 T >C variant (rs2066842) was identified as a marker distinguishing between papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC). Moreover, the c.802 T allele was associated with an enhanced response to RAI treatment, indicating a more substantial decrease in posttreatment stimulated thyroglobulin (sTg) concentrations. The NFKB1A allele c.126A (rs696) exhibited connections with lower FTC stages and a reduced probability of multifocality.  \nConclusion This study explored the molecular mechanisms of particular SNPs, highlighting the role of NOD2 in innate immunity and the stress response, and its potential impact on RAI efficacy. This research underscores the clinical promise of SNP analysis and contributes to personalized treatment strategies for DTC, emphasizing the relevance of genetic factors in cancer progression and treatment outcomes.  \nKeywords Chronic lymphocytic thyroiditis · Differentiated thyroid cancer · Radioiodine treatment · Single nucleotide polymorphisms · Thyroglobulin  \n* M. Borowczyk [martyna.borowczyk@gmail.com](martyna.borowczyk@gmail.com)  \n1 Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 49 Przybyszewskiego Street, 60-355 Poznan, Poland  \n2 Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland  \n3 University Cancer Diagnostic Center, Poznan University of Medical Sciences, Poznan, Poland  \n4 Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Warsaw, Poland  \nIntroduction  \nDifferentiated thyroid cancer (DTC) is the prevailing endocrine malignancy [1] and is predominantly treated with surgery and radioiodine [2] . Despite its generally promising clinical trajectory, patients presenting with distant metastases encounter a significant challenge, with a fiveyear cancer-specific survival rate of merely 40%[3, 4] This population often develops resistance to radioiodine, posing a substantial hurdle in managing their condition [5] .  \nDifferentiated thyroid cancer (DTC) has been shown to potentially be associated with inflammation, particularly chronic lymphocytic thyroiditis (CLT) [5] . Several studies have indicated a potential link between the presence  \nof CLT and an increased risk of developing DTC [6–8] . However, they also showed a protective role of CLT in preventing the spread of DTC by limiting tumor","cbCaiexek4WhasEq","https://ap.wps.com/l/cbCaiexek4WhasEq","pdf",811860,12,"English","# Abstract\n# Introduction\n# Methods and Results\n# Conclusion","[{\"question\":\"What was the purpose of this study on DTC and radioiodine therapy?\",\"answer\":\"The study aimed to determine how specific genes and their germline SNPs, especially those linked to inflammatory and other neoplastic processes, relate to DTC characteristics and to the effectiveness of radioiodine (RAI) treatment.\"},{\"question\":\"How was the patient cohort structured and what genetic testing method was used?\",\"answer\":\"The retrospective cohort included 646 DTC patients diagnosed after thyroidectomy (study period 1998–2014, updated in 2023). SNP selection focused on functional significance, and mutational status was assessed by pyrosequencing.\"},{\"question\":\"Which genetic variants were highlighted as markers for tumor subtype and RAI response?\",\"answer\":\"The NOD2 c.802 T\\u003eC variant (rs2066842) helped distinguish papillary thyroid cancer (PTC) from follicular thyroid cancer (FTC), and the NOD2 c.802 T allele was associated with a stronger RAI response, reflected by greater post-treatment stimulated thyroglobulin (sTg) decrease.\"}]","Germline polymorphisms of the NOD2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment | PDF",1790023596,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea301e8f5318064a36bb9d6d4eb0c80c.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f17d02db4654a476696a297cba367d1d.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47e5c604c06ca71b2a5e4394a4f0275f.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c73861c0a90ceab26d8092ddccf8aa36.webp",980,1301]